Appili Wins Liquid Antibiotic Patent in US
Halifax drug discovery company Appili Therapeutics, which specializes in developing infectious disease treatments, has bagged a United States patent for its liquid formulation of the antibiotic metronidazole.
For Appili, which was founded in 2015, the patent offers control of an alternative to metronidazole’s usual tablet form, which tastes bitter and can prove problematic for patients with